QFIN Q3 Earnings
Qfin reports Q3 2025 earnings, discusses financial performance and outlook.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
KBR Confirms 2026 Revenue Guidance for 2026
KBR confirmed its 2026 revenue guidance.
M impact | EARNINGS | Oct 29, 2026, 01:32 PM UTC
Merck shares rise 3.2% after topping third-quarter estimates
M impact | EARNINGS | Oct 29, 2026, 01:32 PM UTC
Gulf International Services Reports 9-Month Net Profit of 144.6 Million Riyals
M impact | EARNINGS | Oct 29, 2026, 01:31 PM UTC
Merck Says Keytruda Sales Rose 6% to $8.6 Billion in Q3
Keytruda generated nearly half of Merck’s worldwide sales in the third quarter. Merck attributed the drug’s growth to uptake in earlier-stage indications and its new Qlex form.
M impact | EARNINGS | Oct 29, 2026, 01:30 PM UTC
Merck Executive Expects Moderate Top-Line Growth in 2027
A Merck executive said on a conference call that the company expects moderate top-line growth in 2027.
M impact | EARNINGS | Oct 29, 2026, 01:30 PM UTC
Endovastec Nine-Month Revenue Rises 10.26% to RMB 1.12 Billion
M impact | EARNINGS | Oct 29, 2026, 01:25 PM UTC